In his new position, Dr. Ifantides will head the education and clinical efforts of AVG’s forthcoming presbyopia technology platform, according to a Feb. 23 news release.
Dr. Ifantides has a dual background in eye care and bioengineering. He is currently an adjunct assistant professor of ophthalmology at Sue Anschutz-Rodgers Eye Center at the University of Colorado in Aurora and an associate surgeon at Tyson Eye in Cape Coral, Fla., where he specializes in cataract and refractive surgery, with an emphasis on complex cases.
He was previously an assistant professor at the Sue Anschutz-Rodgers Eye Institute and the School of Bioengineering, also in Aurora, Colo., where he managed the department of ophthalmology 3-D printing lab, overseeing engineering graduate students working on various customized medicine solutions for ophthalmology patients.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
